U.S. FDA Accepts New Drug Application for Merck’s Doravirine/Islatravir, an Investigational, Once-Daily, Oral, Two-Drug Regimen for Treatment of Adults with Virologically Suppressed HIV-1 Infection.

The FDA accepted a resubmitted new drug application for reproxalap, a first-in-class investigational topical therapy for dry ...

The FDA accepted Aldeyra's resubmitted NDA for reproxalap after previous rejections due to efficacy concerns, despite no ...

Aug. 8 -- Drug maker Bayer pulled its popular cholesterol-lowering medication off the market today amid reports of a deadly side effect. According to the Food and Drug Administration., Bayer ...

The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug Application (NDA) for ND0612 for the treatment of motor fluctuations in patients with Parkinson disease ...

Researchers at NYU Tandon School of Engineering have developed a new method for creating microscopic drug delivery capsules ...